Joel L. Moake
#158,688
Most Influential Person Now
Joel L. Moake's AcademicInfluence.com Rankings
Joel L. Moakemathematics Degrees
Mathematics
#7284
World Rank
#9927
Historical Rank
Measure Theory
#2017
World Rank
#2447
Historical Rank
Download Badge
Mathematics
Why Is Joel L. Moake Influential?
(Suggest an Edit or Addition)Joel L. Moake's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Platelets and shear stress. (1996) (940)
- ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. (2002) (839)
- Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. (1986) (659)
- Thrombotic thrombocytopenic purpura associated with clopidogrel. (2000) (623)
- Thrombotic microangiopathies. (2002) (365)
- Recent advances in thrombotic thrombocytopenic purpura. (2004) (334)
- Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. (2002) (332)
- Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. (2007) (325)
- This article has been cited by other articles (2003) (323)
- Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. (1993) (296)
- von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. (1991) (288)
- Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. (1992) (287)
- Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. (1987) (286)
- In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. (2012) (234)
- P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. (2004) (226)
- Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin (1988) (223)
- von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. (2004) (206)
- Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. (1988) (203)
- N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. (2011) (202)
- Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. (1985) (182)
- Human endothelial cells synthesize and release ADAMTS‐13 (2006) (176)
- ADAMTS-13 Metalloprotease Interacts with the Endothelial Cell-derived Ultra-large von Willebrand Factor* (2003) (173)
- Haemolytic-uraemic syndrome: basic science (1994) (173)
- Acquired von Willebrand syndrome associated with left ventricular assist device. (2016) (161)
- Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. (1989) (160)
- LYTIC ANTI-ENDOTHELIAL CELL ANTIBODIES IN HAEMOLYTIC-URAEMIC SYNDROME (1988) (159)
- Platelets adhered to endothelial cell‐bound ultra‐large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress (2005) (156)
- Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. (1987) (152)
- Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. (2005) (147)
- Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow. (2001) (144)
- Thrombotic thrombocytopenic purpura (2017) (144)
- Heparin‐induced thrombocytopenia: Association with a platelet aggregating factor and arterial thromboses (1979) (143)
- Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. (2000) (138)
- Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. (1986) (134)
- Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura (1990) (132)
- Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. (2009) (114)
- Thrombosis following desmopressin for uremic bleeding (1988) (106)
- Platelet‐derived VWF‐cleaving metalloprotease ADAMTS‐13 (2005) (106)
- Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis (2013) (104)
- Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura (1998) (104)
- Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions. (2005) (100)
- Thrombotic microangiopathies associated with drugs and bone marrow transplantation. (1996) (99)
- Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura (1992) (95)
- Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. (1989) (94)
- Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura (1989) (94)
- Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. (1994) (93)
- Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets. (1980) (93)
- Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions. (1995) (92)
- Studies on the Mechanisms of Shear-Induced Platelet Activation (1987) (92)
- Conformational stability and domain unfolding of the Von Willebrand factor A domains. (2007) (91)
- Unusually large von willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells (1993) (90)
- Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. (1995) (88)
- Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. (1988) (85)
- Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). (2009) (85)
- Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine (1985) (79)
- Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura (1985) (78)
- Aurintricarboxylic acid in a canine model of coronary artery thrombosis. (1990) (78)
- Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions (2008) (76)
- THE RESPONSE OF HUMAN PLATELETS TO SHEAR STRESS AT SHORT EXPOSURE TIMES (1977) (73)
- Thrombotic thrombocytopenic purpura: the systemic clumping "plague". (2002) (71)
- Platelet lysis and aggregation in shear fields. (1978) (70)
- Platelet response to shear stress: changes in serotonin uptake, serotonin release, and ADP induced aggregation. (1978) (67)
- Studies on the pathophysiology of thrombotic thrombocytopenic purpura. (1997) (66)
- Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. (2009) (66)
- Novel ADAMTS‐13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura (2006) (65)
- Treatment of refractory thrombotic thrombocytopenic purpura with N‐acetylcysteine: a case report (2014) (63)
- ADAMTS‐13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF‐A2 domain as substrate (2004) (62)
- Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings (2015) (60)
- Immunocytochemistry reveals RANKL expression of myeloma cells (2002) (57)
- Thrombotic thrombocytopenic purpura: understanding a disease no longer rare. (1998) (56)
- Bernard‐Soulier Disease: a Study of Four Patients and their Parents (1981) (54)
- Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis. (1987) (53)
- Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. (1989) (51)
- Disulfide bond reduction of von Willebrand factor by ADAMTS‐13 (2010) (48)
- Shear stress-induced binding of von Willebrand factor to platelets. (1997) (48)
- Thrombotic Microangiopathies and the Linkage between von Willebrand Factor and the Alternative Complement Pathway (2014) (47)
- ASPIRIN PREVENTS HEPARIN‐INDUCED PLATELET AGGREGATION IN VIVO (1983) (45)
- Generation and Breakdown of Soluble Ultralarge von Willebrand Factor Multimers (2012) (44)
- Telangiectasia and von Willebrand's disease in two families. (1978) (44)
- Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. (1992) (42)
- Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura (1998) (39)
- Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ibα using optical tweezers (2002) (39)
- Case Series of Thrombotic Thrombocytopenic Purpura in Children and Adolescents (2003) (39)
- Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers. (1991) (38)
- Abnormalities of von willebrand factor multimers in drug‐associated thrombotic microangiopathies (1993) (38)
- Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells (2018) (35)
- TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells (2016) (35)
- Von Willebrand Factor Multimeric Levels and Patterns in Patients With Severe Preeclampsia (1990) (34)
- Fibrinolysis inhibits shear stress-induced platelet aggregation. (1995) (34)
- Prothrombin Houston: a dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation. (1980) (34)
- Human Complement Factor H Is a Reductase for Large Soluble von Willebrand Factor Multimers—Brief Report (2013) (33)
- Differential Effects of Cytochalasin B on Platelet Release, Aggregation and Contractility: Evidence against a Contractile Mechanism for the Release of Platelet Granular Contents (1979) (33)
- ADAMTS‐13 cleaves long von Willebrand factor multimeric strings anchored to endothelial cells in the absence of flow, platelets or conformation‐altering chemicals (2009) (32)
- Direct demonstration of radiolabeled von willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress (1995) (31)
- Mg2+-dependent, (Na+ + K+)-stimulated ATPase of human platelets: Properties and inhibition by ADP (1970) (31)
- Intravascular hemolysis, thrombocytopenia, leukopenia, and circulating immune complexes after jejunal-ileal bypass surgery. (1977) (30)
- In Vitro Comparison of Blood Pump Induced Platelet Microaggregates between a Centrifugal and Roller Pump During Cardiopulmonary Bypass (2002) (29)
- Laminin Peptide-Immobilized Hydrogels Modulate Valve Endothelial Cell Hemostatic Regulation (2015) (27)
- Adhesion of human platelets to purified solid-phase von Willebrand factor: studies of normal and Bernard-Soulier platelets. (1983) (26)
- Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination. (1980) (26)
- Thrombotic Microangiopathies: Multimers, Metalloprotease, and Beyond (2009) (26)
- Case Report: Von Willebrand Factor Abnormalities and Endothelial Cell Perturbation in a Patient with Acute Thrombotic Thrombocytopenic Purpura (1986) (25)
- The effect of PGI2 and theophylline on the response of platelets subjected to shear stress (1981) (25)
- Inhibition of ristocetin-induced platelet agglutination by vancomycin. (1977) (25)
- Fibrillin Containing Elastic Microfibrils Support Platelet Adhesion under Dynamic Shear Conditions (1998) (25)
- Mechanical activation of a multimeric adhesive protein through domain conformational change. (2013) (24)
- Ultralarge von Willebrand factor-induced platelet clumping and activation of the alternative complement pathway in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromes. (2015) (24)
- Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells (2009) (23)
- Effects of Integrelin on platelet function in flow models of arterial thrombosis. (1997) (23)
- Alterations in Hemostatic Parameters During Hemodialysis With Dialyzers of Different Membrane Composition and Flow Design. Platelet Activation and Factor VIII-Related von Willebrand Factor During Hemodialysis (1988) (23)
- Progressive multifocal leukoencephalopathy (1978) (22)
- Spontaneous hyphema associated with ingestion of aspirin and ethanol. (1976) (22)
- Characterization of von Willebrand Factor Interaction with Collagens in Real Time Using Surface Plasmon Resonance (2004) (22)
- Complement activation in thrombotic microangiopathies (2013) (21)
- Shear Stress-Induced Binding of Large and Unusually Large von Willebrand Factor to Human Platelet Glycoprotein Ibα (2004) (18)
- Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor. (2006) (18)
- Familial Infantile Thrombotic Thrombocytopenic Purpura (1996) (17)
- Acquired Von Willebrand Factor Abnormalities in Adults with Congenital Heart Disease: Dependence Upon Cardiopulmonary Pathophysiological Subtype (1998) (16)
- Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts (2020) (16)
- Interaction of Shiga Toxin with the A-domains and Multimers of von Willebrand Factor* (2013) (16)
- Bilateral combined occlusion of the central retinal artery and vein secondary to thrombotic thrombocytopenic purpura. (2000) (15)
- Hemolytic anemia associated with multiple autoantibodies and low serum complement. (1975) (15)
- Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura (2004) (15)
- von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. (1990) (15)
- Circulating IgG antibodies against factors IX and VIII in multiple sclerosis. (1976) (15)
- Rheological studies of the contractile force within platelet-fibrin clots: effects of prostaglandin E1, dibutyryl-cAMP and dibutyryl-cGMP. (1978) (14)
- The effect of PGI2 and theophylline on the response of platelets subjected to shear stress. (1981) (14)
- Thrombotic thrombocytopenic purpura: survival by "giving a dam". (2004) (13)
- Platelets, von Willebrand factor, and prostaglandin I2. (1981) (13)
- Effects of antiplatelet agents on platelets exposed to shear stress. (1980) (13)
- Hairy cell leukemia in association with thrombotic thrombocytopenic purpura and factor VIII antibodies. (1996) (13)
- Morphine-induced immune thrombocytopenia. (1982) (12)
- Dynamic Rheological Studies of Coagulation and Fibrinolysis (1979) (12)
- Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets. (1976) (12)
- POSTPARTUM THROMBOTIC THROMBOCYTOPENIC PURPURA COMPLICATED BY BUDD‐CHIARI SYNDROME (1995) (12)
- Intrathoracic extramedullary hematopoiesis: report of a case in a patient with sickle-cell disease-beta-thalassemia. (1980) (12)
- von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support. (2017) (12)
- Regulatory Components of the Alternative Complement Pathway in Endothelial Cell Cytoplasm, Factor H and Factor I, Are Not Packaged in Weibel-Palade Bodies (2015) (11)
- Effects of colchicine and vinblastine on platelet contractility and release. (1982) (11)
- Complement activation in vivo in cancer patients receiving C. parvum immunotherapy. (1976) (10)
- Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells (1979) (10)
- Direct Detection of Red Blood Cell Fragments: A New Flow Cytometric Method to Evaluate Hemolysis in Blood Pumps (2001) (10)
- Severe hemolysis and red cell fragmentation caused by the combination of a spectrin mutation with a thrombotic microangiopathy (1989) (9)
- Granulocyte proteases do not process endothelial cell‐derived unusually large von willebrand factor multimers to plasma vWF in vivo (1991) (9)
- Journey in reverse: TTP from bedside to blood bank to bench (2007) (8)
- Effects of Prostaglandins, Derivatives of Cyclic 3':5'-AMP, Theophylline, Cholinergic Agents and Colchicine on Clot Retraction in Dilute Platelet-Rich Plasma and Gel-Separated Platelet Test Systems (1977) (7)
- Type IIB von Willebrand's disease: unusual response to cryoprecipitate infusion. (1981) (7)
- Thrombotic thrombocytopenic purpura today. (1999) (7)
- A novel flow cytometric analysis for platelet activation on immobilized von Willebrand factor or fibrillar collagen (2003) (6)
- Ultra-Large Multimers of Von Willebrand Factor form Spontaneous High-Strength Bonds with the Platelet GP Ib-IX Complex : Studies using Optical Tweezers (2002) (6)
- Common bleeding problems. (1983) (6)
- Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells. (1979) (6)
- Transient peripheral plasmacytosis. (1974) (6)
- Effects of PGI2 and di-butyryl cyclic-AMP on platelets exposed to shear stress. (1981) (6)
- Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices (2017) (6)
- Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia (2013) (6)
- von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura. (1998) (6)
- Reversal by adenosine of ADP inhibition of platelet (Na+ + K+)-ATPase. (1970) (5)
- Report on the workshop: Von Willebrand factor and thrombotic thrombocytopenic purpura (2001) (5)
- The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS). (1990) (5)
- Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group. (2005) (5)
- Complement Component C3 Binds to the A3 Domain of von Willebrand Factor (2018) (5)
- Thermodynamic Analysis of Von Willebrand Disease Type 2B and 2M Mutations on the Structural Stability of the Von Willebrand Factor A1 Domain. (2008) (4)
- Sickle cell--betao thalassemia variant with high hemoglobin F and mild clinical course. (1976) (4)
- Thrombotic Thrombocytopenic Purpura and Related Thrombotic Microangiopathies (2013) (4)
- Metabolic requirements of contractile force generation in platelet rich plasma - a rheological study. (1980) (4)
- Single-molecule force measurements of the polymerizing dimeric subunit of von Willebrand factor. (2016) (4)
- Streptokinase-induced degradation of crosslinked and uncrosslinked clots. (1978) (4)
- Correlation of ADAMTS-13 Activity with Response to Plasma Exchange in Patients Diagnosed with Thrombotic Thrombocytopenic Purpura. (2004) (3)
- Thrombotic microangiopathies [4] (multiple letters) (2002) (3)
- von Willebrand factor and the pathophysiology of thrombotic thrombocytopenia: from human studies to a new animal model. (1988) (3)
- A new therapeutic strategy for atypical HUS. (2017) (3)
- Protein Phosphatase 2B Inhibition Promotes the Secretion of Von Willebrand Factor from Endothelial Cells (2008) (3)
- Direct detection of red blood cell fragments: a new flow cytometric method to evaluate hemolysis in blood pumps. (2000) (3)
- Vancomycin effect on thrombin-induced platelet aggregation: evidence against a common platelet membrane receptor for thrombin and ristocetin. (1978) (3)
- Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation (2021) (3)
- von Willebrand factor (vWF) abnormalities in thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS) (1992) (3)
- Hypercoagulable states. (1990) (2)
- Platelets in bloom. (2010) (2)
- Fibrinogen houston: A dysfibrinogen exhibiting defective fibrin monomer aggregation and α‐chain cross‐linkages (1980) (2)
- Recent observations on the pathophysiology of thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. (1990) (2)
- Attack of the acronyms: TTP, VWF, ADAMTS‐13 and SELDI‐TOF‐MS (2006) (2)
- Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group. (2007) (1)
- RAPID, SENSITIVE N0N-RADI0ACTIVE QUANTIFICATION AND ANALYSIS OF PLASMA VON WILLEBRAND FACTOR (vWF) MULTIMERS (1987) (1)
- von Willebrand factor in thrombotic thrombocytopenic purpura. (1986) (1)
- Hypercoagulable states: new knowledge about old problems. (1991) (1)
- Thrombotic Thrombocytopenic Purpura, Hemolytic–Uremic Syndrome, and HELLP (2011) (1)
- Platelet factor 4 does not promote von Willebrand factor binding to human platelets. (1984) (1)
- aggregation and prevents episodes of thrombotic thrombocytopenic Solvent/detergent-treated plasma suppresses shear-induced platelet (2011) (1)
- Correlating Conformational Dynamics with the Von Willebrand Factor Reductase Activity of Factor H Using Single Molecule Force Measurements. (2018) (1)
- Insolubilized von Willebrand factor and the initial events in hemostasis. (1989) (1)
- Severe proliferative retinopathy as the only sign of sickle cell hemoglobin C disease. (1976) (1)
- platelet membrane glycoproteins Ib and IIb-IIIa Shear-induced platelet aggregation requires von Willebrand factor and (2011) (0)
- Thrombotic disorders. (1985) (0)
- The Conformation of Factor H Determines its Von Willebrand Factor Reductase Activity (2018) (0)
- Contributors (2019) (0)
- Detection of circulating platelet microaggregates and surface microthrombi during continuous flow LVAD: evidence for shear-induced platelet activation (2002) (0)
- Qualitative Defect In The Factor VIII/Von Willebrand Factor Protein (FVIII/VWF) In A Family With Hereditary Hemorrhagic Telangiectasia (HHT) (1981) (0)
- Heat-inactivated Factor B inhibits alternative pathway fluid-phase activation and convertase formation on endothelial cell-secreted ultra-large von Willebrand factor strings (2023) (0)
- Inhibitors of von Willebrand Factor Binding to Platelet Glycoprotein Ib (2002) (0)
- Investigating the Mechanical Properties of Plasma von Willebrand Factor Using Atomic Force Microscopy (2010) (0)
- cell secretion and impair ADAMTS-13 cleavage of unusually large von Hemolytic uremic syndrome-associated Shiga toxins promote endothelial (2013) (0)
- The Centre for Blood Research presents The Earl W. Davie Symposium (2015) (0)
- Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts (2020) (0)
- Platelet function, surface structure and antigenicity. (1990) (0)
- Investigating intermolecular forces associated with thrombus initiation using optical tweezers (2002) (0)
- United States Patent ( 19 ) Moake et al . 54 METHOD FOR PREVENTING AND TREATING THROMBOSS (2017) (0)
- Study of Large Multimeric Biomolecules by Single-Molecule Manipulation and Imaging (2012) (0)
- ADAMTS-13 Has a Disulfide Bond Reduction Activity on Von Willebrand Factor (2008) (0)
- Unusually Largevon Willebrand FactorMultimers Increase AdhesionofSickle Erythrocytes toHumanEndothelial CellsunderControlled Flow (1987) (0)
- Chapter 24 – Thrombotic Thrombocytopenic Purpura (2007) (0)
- Biomechanical Stimuli Effects on Valve Endothelial Cell Anti-thrombotic Mechanisms (2012) (0)
- PLATELETS AND VON WILLEBRAND FACTOR INTERACTIONS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): ASSOCIATION WITH THROMBOCYTOPENIA AND THROMBOSIS (2017) (0)
- FLOW CYTOMETRIC ASSAY TO QUANTIFY PUMP INDUCED MICROTHROMBI DURING CARDIOPULMONARY BYPASS (2000) (0)
- Protein Phosphatase 2B Inhibitor, Cyclosporine A, Stimulates Endothelial Cell Exocytosis of Ultra-Large VWF Multimeric Strings by Regulating Munc18c Phosphorylation. (2007) (0)
- Factor H (FH) Is Released Slowly and Continuously from Human Endothelial Cells (ECs): FH Is Not Packaged in Weibel-Palade Bodies or Secreted in Response to EC Stimulation (2014) (0)
- Factor H Binds to Von Willebrand Factor (VWF) and Regulates Its Cleavage by ADAMTS-13 (2008) (0)
- Willebrand Factor A-domains and Multimers of von Interaction of Shiga Toxin with the Protein Structure and Folding : (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joel L. Moake?
Joel L. Moake is affiliated with the following schools:
